[1]王尚全 张军 赵国东 孙树椿 宋雨霖 尹煜辉.颈Ⅲ号方治疗椎动脉型颈椎病的临床报道[J].中国中医骨伤科杂志,2021,29(03):46-48.
　WANG Shangquan ZHANG Jun ZHAO Guodong SUN Shuchun SONG Yulin YIN Yuhui.Clinical Efficacy Analysis of Treatment for Vertebral Artery Type Cervical Spondylosis by Jing Ⅲ Prescription[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2021,29(03):46-48.
点击复制

颈Ⅲ号方治疗椎动脉型颈椎病的临床报道()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第29卷
期数:
2021年03期
页码:
46-48
栏目:
临床报道
出版日期:
2021-03-15

文章信息/Info

Title:
Clinical Efficacy Analysis of Treatment for Vertebral Artery Type Cervical Spondylosis by Jing Ⅲ Prescription
文章编号:
1005-0205(2021)03-0046-03
作者:
王尚全 张军 赵国东 孙树椿 宋雨霖 尹煜辉
1中国中医科学院望京医院(北京,100102 )△通信作者 E-mail:13901147122@163.com
Author(s):
WANG Shangquan ZHANG Jun ZHAO Guodong SUN Shuchun SONG Yulin YIN Yuhui
1Wangjing Hospital,China Academy of Chinese Medical Sciences,Beijing 100102,China.
关键词:
颈Ⅲ号方;  椎动脉型颈椎病;  有效性;  安全性
Keywords:
Jing Ⅲ prescription;  vertebral artery type cervical spondylosis;  efficacy;  safety
分类号:
R681.5
文献标志码:
B
摘要:
目的:收集孙树椿教授临床应用颈Ⅲ号方治疗椎动脉型颈椎病病例,观察其有效性及安全性。方法:回顾性总结采用颈Ⅲ号方治疗椎动脉型颈椎病患者6 089例,根据临床疗效及FS-CAS评分评价其有效性和安全性。结果:临床有效率构成中显效5 176例(85.01%),有效386例(6.34%),无效527例(8.65%),总有效率达91.35%,其中仅有2例(0.30%)在服药后出现轻度恶心,调整服药时间后症状消失; FS-CAS评分在治疗后与治疗前相比差异有统计学意义(P<0.05)。结论:颈Ⅲ号方在临床中治疗椎动脉型颈椎病具有良好的疗效,能改善患者临床头晕目眩等症状,并且副作用少,具有良好的安全性。
Abstract:
To study the efficacy and safety of Professor Sun Shuchun’s Jing Ⅲ prescription in treating vertebral artery type cervical spondylosis.Methods:6 089 patients with vertebral artery type cervical spondylosis who were treated by Jing Ⅲ prescription were retrospectively summarized.The efficacy and safety were evaluated by clinical efficacy and FS-CAS score.Results:There were 5 176 cases(85.01%)with marked effect,386 cases(6.34%)with effective effect,527 cases(8.65%)with ineffective effect,and the total effective rate was 91.35%.Only 2 cases(0.30%)showed mild nausea after taking the medicine,and the symptoms disappeared after adjusting the time of taking the medicine.The FS-CAS score showed statistical significance after treatment compared with before treatment(P<0.05).Conclusion: Jing Ⅲ prescription has satisfied efficacy in the treatment of vertebral artery type cervical spondylosis.It shows well safety in improving clinical dizziness and other symptoms without obvious side-effect.

参考文献/References:

[1] 胥少汀,葛宝丰,徐印坎.实用骨科学[M].北京:人民军医出版社,2005:1422-1427.
[2] 罗晓,刘康,杨维新.某医院2014-2016年颈椎病住院患者流行病学现状分析[J].解放军预防医学杂志,2018,36(1):124-126.
[3] 国家食品药品监督管理局.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:346.
[4] 张军,唐东昕,李俊海,等.孙氏筋伤手法脉系源流追溯考究[J].中国中医骨伤科杂志,2007,15(3):51-52.
[5] 中华外科杂志编辑部.颈椎病的分型、诊断及非手术治疗专家共识(2018版)[J].中华外科杂志,2018,56(6):401-402.
[6] 国家中医药管理局.中医病证诊断疗效标准[S].南京:南京大学出版社:1994:189.
[7] 魏毅,梁伟雄,蔡业峰.椎动脉型颈椎病功能评定量表(FS-CSA)的初步建立[J].中国康复医学杂志,2003,18(7):410-412.
[8] 唐东昕,张军,张淳,等.孙树椿治疗颈椎病经验介绍[J].新中医,2007,39(6):6-7.
[9] 李亚军,何霞,师振江,等.椎动脉型颈椎病发病机制研究进展[J].临床医学研究与实践,2017,2(9):194-195.
[10] 赵忠民,张军,刘秀芹,等.浅析在孙树椿筋伤理论的指导下手法治疗颈椎病[J].中国中医骨伤科杂志,2011,19(4):58-59.
[11] 张清.椎动脉型颈椎病的X线观察与诊断[J].中国中医骨伤科杂志,2000,8(1):28-30.
[12] 陈朝晖,唐东昕,王立恒,等.孙树椿诊治筋伤特点初探[J].中国中医骨伤科杂志,2007,15(4):63-64.
[13] 李燕,谢淼,邵明莎,等.近10年来天麻的药理作用及化学成分研究进展[J].中华中医药学刊,2017,35(12):2987-2993.
[14] CHAPLEAU M W,HAJDUCZOK G,SHARMA R V,et al.Mechanisms of baroreceptor activation[J].Clin Exp Hypertens,1995,17(1/2):1-13.
[15] 倪红霞,王春梅.白芷总香豆素联合白芷挥发油对大鼠偏头痛的预防作用及其机制[J].吉林大学学报(医学版),2018,44(3):487-492.
[16] 王春梅,孙晶波,刘惠民.白芷总香豆素和白芷总挥发油配伍药效学比较[J].北华大学学报(自然科学版),2015,16(4):450-453.
[17] 吴辉,王帆,魏丹,等.白芷、吴茱萸、川芎对偏头痛大鼠血清NO,5-HT含量及脑干组织CGRP表达的影响[J].湖北中医药大学学报,2018,20(6):17-20.
[18] 罗仁书,何治勇.川芎有效成分药理作用的研究进展[J].中国医院用药评价与分析,2018,18(9):1294-1296.
[19] 孙华,李春燕,薛金涛.葛根的化学成分及药理作用研究进展[J].新乡医学院学报,2019,36(11):1097-1101.

备注/Memo

备注/Memo:
基金项目:中国中医科学院课题(ZZ10-015)国家旅游局文化部非遗项目(Ⅸ-6)
更新日期/Last Update: 2021-03-15